Girth body sizes in men with psoriasis of different somatotypes

  • Obadeh Bassam Abdel-Rahman Al-Qaraleh National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • S. V. Dmytrenko National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • А. І. Kondratiuk National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • I. A. Golubovsky National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • T. O. Rekun National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: psoriasis, girth body sizes, somatotype, men.

Abstract

Psoriasis, despite its seemingly simple clinic and course, is at the same time a complex socio-economic phenomenon that causes stigmatization of people with this disease. The use of constitutional markers to predict the risk and severity of psoriasis could be a promising way to alleviate this problem. The aim of the study was to establish and analyze the differences in girth body sizes between healthy and/or psoriatic Ukrainian men of different somatotypes depending on the severity of the disease. On the basis of the Military Medical Clinical Center of the Central Region and the Department of Skin and Venereal Diseases with a course of postgraduate education of National Pirogov Memorial Medical University, Vinnytsya, the determination of body sizes’ in men aged 22 to 35 years, suffering from psoriasis of mild (n=32) and severe (n=68) course was carried out. Clinical assessment of the severity and area of psoriatic lesions was performed using the PASI index. Determination of somatotype was performed according to the Heath Carter method. As a control from the data bank of the research center of National Pirogov Memorial Medical University, Vinnytsya anthropometric data of 82 practically healthy men of the same age group were selected. Statistical processing of the obtained results was performed in the license package "Statistica 5.5" using non-parametric evaluation methods. Compared with healthy men of the corresponding somatotypes, it was found: in patients with mild and severe psoriasis men of mesomorphic somatotype – significantly higher, or a tendency to greater values of almost all girth body sizes (except foot girth, and only in patients with mild course – girth of forearms in the lower part); only in patients with mild psoriasis men of endo-mesomorphic somatotype – significantly higher, or a tendency to higher values of almost all girth body sizes (except for the girth of the foot and lower leg in the lower part). In patients with psoriasis men of endo-mesomorphic somatotype with a mild course of the disease significantly higher, or a tendency to greater values than in patients with a similar course men of mesomorphic somatotype shoulder girth in stressed and unstressed state, forearms, upper and lower arms thighs, hips, shins in the upper part, neck, waist and all the girths of the chest; and in patients with psoriasis men of mesomorphic somatotype with a severe course of the disease – only tendencies to greater values than in patients with a similar course men of endo-mesomorphic somatotype girth of thighs and shin in the upper part. In patients with mild psoriasis men, the differences in body sizes between mesomorphic and endo-mesomorphic somatotypes are similar to healthy men, but are more pronounced. When comparing the girth of the body between psoriasis patients Ukrainian men of the corresponding somatotypes, representatives of the mesomorphic somatotype with severe disease have significantly higher, or a tendency to greater values than with mild course, the girth values of the forearms at the top, neck, waist and all around chest, as well as the tendency to lower values of the girth of the shin. The established pronounced differences in the girth sizes of the body provide an opportunity to identify risk groups for the occurrence and features of psoriasis.

References

[1] Armstrong, A. W., Schupp, C., Wu, J., & Bebo, B. (2012). Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003–2011. PloS one, 7(12), e52935. doi: 10.1371/journal.pone.0052935
[2] Augustin, M., Krüger, K., Radtke, M. A., Schwippl, I., & Reich, K. (2008). Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology, 216(4), 366-372. doi: 10.1159/000119415
[3] Aune, D., Snekvik, I., Schlesinger, S., Norat, T., Riboli, E., & Vatten, L. J. (2018). Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose–response meta-analysis of prospective studies. European journal of epidemiology, 33(12), 1163-1178. doi: 10.1007/s10654-018-0366-z
[4] Bunak, V. V. (1941). Antropometriia [Anthropometry]. М.: Narkompros RSFSR – М.: People's Commissariat of the RSFSR.
[5] Capon, F. (2017). The genetic basis of psoriasis. International journal of molecular sciences, 18(12), 2526. doi: 10.3390/ijms18122526
[6] Carter, J. (2003). The Heath-Carter antropometric somatotype. Instruction manual. Department of Exercise and Nutritional Sciences San Diego State University. CA. U.S.A.
[7] Dai, Y. X., Shen, Y. J., Chou, Y. J., Chang, Y. T., Chen, T. J., Li, C. P., & Wu, C. Y. (2020). Obesity, but not metabolic diseases, is associated with risk of psoriasis: a population-based cohort study in Taiwan. Dermatology, 236(6), 521-528. doi: 10.1159/000508303
[8] Enamandram, M., & Kimball, A. B. (2013). Psoriasis epidemiology: the interplay of genes and the environment. Journal of Investigative Dermatology, 133(2), 287-289. doi: 10.1038/jid.2012.434
[9] Fredriksson, T., & Pettersson, U. (1978). Severe psoriasis – oral therapy with a new retinoid. Dermatology, 157(4), 238-244. doi: 10.1159/000250839
[10] Han, J. H., Lee, J. H., Han, K. D., Kim, H. N., Bang, C. H., Park, Y. M., ... & Kim, T. Y. (2019). Increased risk of psoriasis in subjects with abdominal obesity: A nationwide population‐based study. The Journal of dermatology, 46(8), 695-701. doi: 10.1111/1346-8138.14939
[11] Heller, M. M., Lee, E. S., & Koo, J. Y. (2011). Stress as an influencing factor in psoriasis. Skin therapy letter, 16(5), 1-4. PMID: 21611682
[12] Hrehorów, E., Salomon, J., Matusiak, U., Reich, A., & Szepietowski, J. C. (2012). Patients with psoriasis feel stigmatized. Acta dermato-venereologica, 92(1), 67-72.
[13] Kim, M., Han, K. D., & Lee, J. H. (2020). Bodyweight variability and the risk of psoriasis: a nationwide population‐based cohort study. Journal of the European Academy of Dermatology and Venereology, 34(5), 1019-1025. doi: 10.1111/jdv.16099
[14] Li, W. Q., Han, J. L., Zhang, M. F., & Qureshi, A. A. (2013). Interactions between adiposity and genetic polymorphisms on the risk of psoriasis. British Journal of Dermatology, 168(3), 639-642. doi: 10.1111/bjd.12001
[15] Michalek, I. M., Loring, B., & John, S. M. (2017). A systematic review of worldwide epidemiology of psoriasis. Journal of the European Academy of Dermatology and Venereology, 31(2), 205-212. doi: 10.1111/jdv.13854
[16] Norden, A., Rekhtman, S., Strunk, A., & Garg, A. (2021). Risk of psoriasis according to body mass index: a retrospective cohort analysis. Journal of the American Academy of Dermatology. doi: 10.1016/j.jaad.2021.06.012
[17] Obadeh Bassam Abdel-Rahman Al-Qaraleh, Dmytrenko, S. V., Shayuk, A. V., Gunas, I. V., & Prokopenko S. V. (2020). Peculiarities of girth body sizes in men with mild and severe psoriasis course. Reports of Morphology, 26(4), 62-67. doi: 10.31393/morphology-journal-2020-26(4)-10
[18] Parisi, R., Symmons, D. P., Griffiths, C. E., & Ashcroft, D. M. (2013). Global epidemiology of psoriasis: a systematic review of incidence and prevalence. Journal of Investigative Dermatology, 133(2), 377-385. doi: 10.1038/jid.2012.339
[19] Rachakonda, T. D., Schupp, C. W., & Armstrong, A. W. (2014). Psoriasis prevalence among adults in the United States. Journal of the American Academy of Dermatology, 70(3), 512-516. doi: 10.1016/j.jaad.2013.11.013
[20] Snekvik, I., Smith, C. H., Nilsen, T. I., Langan, S. M., Modalsli, E. H., Romundstad, P. R., & Saunes, M. (2017). Obesity, waist circumference, weight change, and risk of incident psoriasis: prospective data from the HUNT study. Journal of Investigative Dermatology, 137(12), 2484-2490. doi: 10.1016/j.jid.2017.07.822
[21] Toussirot, É., Aubin, F., & Dumoulin, G. (2014). Relationships between adipose tissue and psoriasis, with or without arthritis. Frontiers in immunology, 5, 368. doi: 10.3389/fimmu.2014.00368
[22] Tsai, T. F., Wang, T. S., Hung, S. T., Phiona, I., Tsai, C., Schenkel, B., ... & Tang, C. H. (2011). Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. Journal of dermatological science, 63(1), 40-46. doi: 10.1016/j.jdermsci.2011.03.002
[23] Vanderpuye-Orgle, J., Zhao, Y., Lu, J., Shrestha, A., Sexton, A., Seabury, S., & Lebwohl, M. (2015). Evaluating the economic burden of psoriasis in the United States. Journal of the American Academy of Dermatology, 72(6), 961-967. doi: 10.1016/j.jaad.2015.02.1099
[24] Zachariae, C., & Skov, L. (2020). Obesity as a risk factor for psoriasis. Journal of the European Academy of Dermatology and Venereology, 34(5), 915-916. doi: 10.1111/jdv.16434
Published
2021-06-26
How to Cite
Abdel-Rahman Al-Qaraleh, O. B., Dmytrenko, S. V., KondratiukА. І., Golubovsky, I. A., & Rekun, T. O. (2021). Girth body sizes in men with psoriasis of different somatotypes. Biomedical and Biosocial Anthropology, (43), 24-28. https://doi.org/10.31393/bba43-2021-04